Abstract
Purpose
To derive the best magnetic resonance enterography (MRE) approach for detecting activity and severe lesions in Crohn’s disease (CD) to use for selecting patients and measuring response to treatment in clinical trials.
Methods
We compared the accuracies of MRE (T2-weighted sequences, DWI (b = 800 s/mm2) sequences, combined T2-weighted and DWI sequences, combined T2-weighted or DWI sequences, and MaRIA score based on T2-weighted and contrast-enhanced T1-weighted sequences) versus ileocolonoscopy (SES-CD) performed within 1 month. Bowel segments were classified as inactive (SES-CD < 2), active (SES-CD ≥ 2), or active with severe lesions (ulcers seen at endoscopy). McNemar’s test was used to compare the accuracies of the different approaches against endoscopy.
Results
224 segments in 43 patients were analyzed. For detecting active disease, the combination of findings from T2 and DWI sequences results in the highest specific and accurate sequence combination. Combined T2-weighted and DWI sequences had similar sensitivity to those of MaRIA (P = 0.25) but lower specificity (P = 0.007) and accuracy (P = 0.0013) than MaRIA score. For detecting severe lesions, T2-weighted sequences alone had greater accuracy [similar to MaRIA score (P > 0.999)] than other noncontrast approaches.
Conclusions
T2-weighted sequences should be used as a first screening step, and followed by contrast-enhanced T1-weighted sequences only when abnormal findings are identified; adding DWI does not improve the accuracy of MRE.
Similar content being viewed by others
Abbreviations
- CD:
-
Crohn’s disease
- DWI:
-
Diffusion-weighted imaging
- MRE:
-
Magnetic resonance enterography
- CI:
-
Confidence interval
- SES-CD:
-
Simplified endoscopic score for Crohn disease
- Anti-TNF:
-
Anti-tumor necrosis factor
References
Peyrin-Biroulet L, Reinisch W, Colombel J-F, et al. (2014) Clinical disease activity, C-reactive protein normalisation and mucosal healing in Crohn’s disease in the SONIC trial. Gut 63:88–95
Jauregui-Amezaga A, Rimola J, Ordás I, et al. (2015) Value of endoscopy and MRI for predicting intestinal surgery in patients with Crohn’s disease in the era of biologics. Gut 64:1397–1402
Coimbra AJF, Rimola J, O’Byrne S, et al. (2016) Magnetic resonance enterography is feasible and reliable in multicenter clinical trials in patients with Crohn’s disease, and may help select subjects with active inflammation. Aliment Pharmacol Ther 43:61–72
Panes J, Bouhnik Y, Reinisch W, et al. (2013) Imaging techniques for assessment of inflammatory bowel disease: joint ECCO and ESGAR evidence-based consensus guidelines. J Crohns Colitis 7:556–585
Horsthuis K, Bipat S, Bennink RJ, Stoker J (2008) Inflammatory bowel disease diagnosed with US, MR, scintigraphy, and CT: meta- analysis of prospective studies. Radiology 247:64–79
Panés J, Bouzas R, Chaparro M, et al. (2011) Systematic review: the use of ultrasonography, computed tomography and magnetic resonance imaging for the diagnosis, assessment of activity and abdominal complications of Crohn’s disease. Aliment Pharmacol Ther 34:125–145
ACR Committe on Drgs and Contrast Media (2015) ACR manual on contrast media version 10.1. ACR
Seo N, Park SH, Kim K-J, et al. (2016) MR Enterography for the evaluation of small-bowel inflammation in Crohn disease by using diffusion- weighted Imaging without intravenous contrast material: a prospective noninferiority study. Radiology 278:762–772
Choi SH, Kim KW, Lee JY, Kim K, Park SH (2016) Diffusion-weighted magnetic resonance enterography for evaluating bowel inflammation in Crohn ’ s disease : a systematic. Inflamm Bowel Dis 22:669–679
Oussalah A, Laurent V, Bruot O, et al. (2010) Diffusion-weighted magnetic resonance without bowel preparation for detecting colonic inflammation in inflammatory bowel disease. Gut 59:1056–1065
Kim K-J, Lee Y, Park SH, et al. (2015) Diffusion-weighted MR enterography for evaluating Crohn’s disease: how does it add diagnostically to conventional MR enterography? Inflamm Bowel Dis 21:101–109
Harvey RF, Bradshaw JM (1980) A simple index of Crohn’s-disease activity. Lancet 1:514
Daperno M, D’Haens G, Van Assche G, et al. (2004) Development and validation of a new, simplified endoscopic activity score for Crohn’s disease: the SES-CD. Gastrointest Endosc 60:505–512
Rimola J, Rodriguez S, Garcia-Bosch O, et al. (2009) Magnetic resonance for assessment of disease activity and severity in ileocolonic Crohn’s disease. Gut 58:1113–1120
Rimola J, Ordás I, Rodriguez S, et al. (2011) Magnetic resonance imaging for evaluation of Crohn's disease. Inflamm Bowel Dis 17:1759–1768
Steward MJ, Punwani S, Proctor I, et al. (2012) Non-perforating small bowel Crohn’s disease assessed by MRI enterography: derivation and histopathological validation of an MR-based activity index. Eur J Radiol 81:2080–2088
Dohan A, Taylor S, Hoeffel C, et al. (2016) Diffusion-weighted MRI in Crohn ’ s disease: current status and recommendations. J Magn Reson Imaging 44:1381–1396
Maccioni F, Bruni A, Viscido A, Colaiacomo MC, Cocco A (2006) MR imaging in patients with Crohn disease : value of T2- versus T1-weighted gadolinium-enhanced MR sequences with use of an oral superparamagnetic contrast agent. Radiology 238:517–530
Sato H, Tamura C, Narimatsu K, et al. (2015) Magnetic resonance enterocolonography in detecting erosion and redness in intestinal mucosa of patients with Crohn’s disease. J Gastroenterol Hepatol 30:667–673
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
Authors have nothing to disclose.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Rimola, J., Alvarez-Cofiño, A., Pérez-Jeldres, T. et al. Increasing efficiency of MRE for diagnosis of Crohn’s disease activity through proper sequence selection: a practical approach for clinical trials. Abdom Radiol 42, 2783–2791 (2017). https://doi.org/10.1007/s00261-017-1203-7
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00261-017-1203-7